| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-08 |